TOP > 外国特許検索 > Method for detecting regulatory T cells using expression of folate receptor 4 as indicator, method for treating diseases using the detection method, pharmaceutical composition for immunostimulation, and method for treating diseases using the composition

Method for detecting regulatory T cells using expression of folate receptor 4 as indicator, method for treating diseases using the detection method, pharmaceutical composition for immunostimulation, and method for treating diseases using the composition

外国特許コード F150008441
整理番号 734
掲載日 2015年10月21日
出願国 アメリカ合衆国
出願番号 24036105
公報番号 20060246063
公報番号 7488474
出願日 平成17年10月3日(2005.10.3)
公報発行日 平成18年11月2日(2006.11.2)
公報発行日 平成21年2月10日(2009.2.10)
優先権データ
  • 特願2005-134279 (2005.5.2) JP
発明の名称 (英語) Method for detecting regulatory T cells using expression of folate receptor 4 as indicator, method for treating diseases using the detection method, pharmaceutical composition for immunostimulation, and method for treating diseases using the composition
発明の概要(英語) (US7488474)
An object of the present invention is to provide a technique to distinguish between Treg cells and activated T cells in a live state.
Another object of the present invention is to provide a pharmaceutical composition for immunostimulation that can reduce the number of Treg cells in vivo and effectively express the immune response of activated T cells.
In the method of the present invention, Treg cells are detected from test cells containing (i) regulatory T cells and (ii) at least one type of cell selected from the group consisting of naive T cells and activated T cells, wherein expressions of folate receptor 4 on the surfaces of cells are measured and Treg cells are detected using the expressions as an indicator.
The present invention uses anti-folate receptor 4 antibody or folate receptor 4-binding fragment as an active ingredient contained in a pharmaceutical composition for immunostimulation.
特許請求の範囲(英語) [claim1]
1. A method for treating a malignant tumor or infectious disease comprising:
(a) collecting cells comprising T cells from a patient suffering from a malignant tumor or infectious disease;(b) inducing the T cells in the cells collected in (a) by subjecting the cells collected to an antigenic stimulus in vitro;(c) depleting from the resulting cells of (b), cells having the highest folate receptor 4 expression, so as to obtain cells comprising T cells from which regulatory T cells have been removed;
and(d) administering the resulting depleted cells obtained in (c) to the patient.
[claim2]
2. The method of claim 1, wherein step (c) is carried out by the method comprising:
(i) measuring expression of folate receptor 4 on the surface of the T cells;(ii) detecting regulatory T cells using the expression as an indicator;
and(iii) depleting regulatory T cells having the highest folate receptor 4 expression.
[claim3]
3. The method of claim 1, wherein the folate receptor 4 expression is measured using an anti-folate receptor 4 antibody or a folate receptor 4-binding fragment.
  • 発明者/出願人(英語)
  • SAKAGUCHI SHIMON
  • HIROTA KEIJI
  • YAMAGUCHI TOMOYUKI
  • KYOTO UNIVERSITY
  • RIKEN
国際特許分類(IPC)
米国特許分類/主・副
  • 424/93.71
ライセンスをご希望の方、特許の内容に興味を持たれた方は、下記までご連絡ください。

PAGE TOP

close
close
close
close
close
close